Search Within

Eric J Sherman

  1. "Biostatistics Service"
Formats
  1. Journal Article (34)
  2. Meeting Abstract (33)
Groups
  1. Biostatistics Service (67)
  2. Department of Medicine (67)
  3. Epidemiology and Biostatistics (67)
  4. Head and Neck Service (67)
  5. Solid Tumor Oncology Division (67)
  6. Radiation Oncology, Department of (47)

More Groups

People
  1. David Pfister (49)
  2. Nancy Lee (44)
  3. Zhigang Zhang (34)
  4. Nadeem Riaz (29)
  5. Alan Ho (27)
  6. Richard Wong (25)

More People

Years
  1. 2024 (9)
  2. 2023 (3)
  3. 2022 (3)
  4. 2021 (6)
  5. 2020 (4)
  6. 2019 (5)

More Years

Publications
  1. Journal of Clinical Oncology (21)
  2. International Journal of Radiation Oncology, Biology, Physics (19)
  3. Annals of Oncology (4)
  4. Cancer (3)
  5. Laryngoscope (3)
  6. International Journal of Cancer (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (21)
  2. Elsevier Inc. (20)
  3. Wiley Blackwell (7)
  4. Oxford University Press (6)
  5. American Association for Cancer Research (2)
  6. John Wiley & Sons (2)

More Publishers

Results (67)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of lenvatinib in patients with progressive, recurrent/metastatic adenoid cystic carcinoma
    Meeting Abstract

    Tchekmedyian, V.; Sherman, E. J.; Dunn, L.; Tran, C.; Katabi, N.; Ni, A.; Haque, S.; Pfister, D. G.; Ho, A. L.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase II randomized trial of nivolumab with stereotactic body radiotherapy (SBRT) versus nivolumab alone in metastatic (M1) head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    McBride, S. M.; Sherman, E. J.; Tsai, C. J.; Baxi, S. S.; Aghalar, J.; Eng, J.; Zhi, W. I.; McFarland, D. C.; Michel, L. S.; Spielsinger, D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Integrated genomic analysis of Hurthle cell carcinoma reveals TMEM233/PRKAB1 fusion as a novel oncogenic driver
    Meeting Abstract

    Dong, Y.; Ganly, I.; Makarov, V.; Kuo, F.; Deraje, S.; Reznik, E.; Seshan, V.; Nanjangud, G.; Morris, L.; Riaz, N.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Long-term outcomes in oral cavity squamous cell carcinoma with adjuvant and salvage radiotherapy after surgery
    Journal Article

    Katsoulakis, E.; Leeman, J. E.; Lok, B. H.; Shi, W.; Zhang, Z.; Tsai, J. C.; McBride, S. M.; Sherman, E. J.; Cohen, M.; Wong, R.; more...
    Laryngoscope (2018)

    Fulltext@MSK | Save
  • Metastasis directed therapy with definitive intent is associated with improved survival in metastatic head and neck cancer
    Meeting Abstract

    Leeman, J. E.; Beckham, T.; Xie, P.; Li, X.; Spielsinger, D.; Goldman, D. A.; Zhigang, Z.; Sherman, E.; McBride, S.; Riaz, N.; more...
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • Integrated genomic analysis of Hürthle cell cancer reveals oncogenic drivers, recurrent mitochondrial mutations, and unique chromosomal landscapes
    Journal Article

    Ganly, I.; Makarov, V.; Deraje, S.; Dong, Y.; Reznik, E.; Seshan, V.; Nanjangud, G.; Eng, S.; Bose, P.; Kuo, F.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Salvage radiotherapy leads to worse overall survival compared to adjuvant radiotherapy in oral cavity carcinoma: A matched analysis
    Meeting Abstract

    Katsoulakis, E.; Leeman, J. E.; Shi, W.; Zhigang, Z.; Morris, L.; Sherman, E.; Cohen, M.; Tsai, C. J.; McBride, S.; Ganly, I.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • The toxicity and efficacy of concomitant chemoradiotherapy in patients aged 70 years and older with oropharyngeal carcinoma in the intensity-modulated radiotherapy era
    Journal Article

    Zumsteg, Z. S.; Lok, B. H.; Ho, A. S.; Drill, E.; Zhang, Z.; Riaz, N.; Shiao, S. L.; Ma, J.; McBride, S. M.; Tsai, C. J.; more...
    Cancer (2017)

    Fulltext@MSK | Save
  • Phase II study of regorafenib in progressive, recurrent/metastatic adenoid cystic carcinoma
    Meeting Abstract

    Ho, A. L.; Sherman, E. J.; Baxi, S. S.; Haque, S.; Ni, A.; Antonescu, C. R.; Katabi, N.; Morris, L. G.; Chan, T. A. T.; Pfister, D. G.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Enhancing radioiodine (RAI) incorporation into BRAF(V600E)-mutant, RAI-refractory thyroid cancers with the BRAF inhibitor vemurafenib: A pilot study
    Meeting Abstract

    Dunn, L.; Sherman, E. J.; Baxi, S. S.; Grewal, R. K.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M.; Fish, S.; Boucai, L.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save